Anne Armstrong
Christie NHS Foundation Trust · The Christie NHS Foundation Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anne Armstrong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:59 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05093426 · PERSONAL - Sleep In Breast CancerClosed Loop Medicine · completed · Insomnia, Breast Cancer · principal investigator
- Ph2NCT04188119 · A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerThe Christie NHS Foundation Trust · withdrawn · Breast Cancer · principal investigator
- Ph2NCT03794596 · A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerThe Christie NHS Foundation Trust · withdrawn · Breast Cancer · principal investigator
- Ph1/Ph2NCT01791985 · AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)Imperial College London · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Validation of a Prenatal Alcohol and Drug Screening ToolR01AA014386 · NIAAA · KAISER FOUNDATION HEALTH PLAN · fiscal years 2005 to 2008 · $476,322 awarded in 2008Same name and institution; not confirmed by an ID
- HOW MUCH DOES SHE REALLY DRINK? AN HMO INTERVENTIONR01AA012486 · NIAAA · KAISER FOUNDATION RESEARCH INSTITUTE · fiscal years 2003 · $336,282 awarded in 2003Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:59 UTC. The ranking covers the 200 most relevant of 280 PubMed records, and a shared surname and initials can bring in a namesake. All 280 on PubMed
- Increased survival with enzalutamide in prostate cancer after chemotherapy.N Engl J Med · 20123,750 citationsRCR 102.0
- 2,672 citationsRCR 86.7
- Enzalutamide in metastatic prostate cancer before chemotherapy.N Engl J Med · 20142,392 citationsRCR 70.7
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.J Clin Oncol · 20191,003 citationsRCR 39.5
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.N Engl J Med · 2015675 citationsRCR 25.2
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.N Engl J Med · 2016623 citationsRCR 26.5
- 619 citationsRCR 21.9
- 600 citationsRCR 26.1
- 548 citationsRCR 19.1
- Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.Hepatology · 2009475 citationsRCR 12.9